In this column for the JAMA Forum, KFF’s Larry Levitt explores the Medicare drug-price negotiation provisions and other significant drug-price changes in the Inflation Reduction Act and their potential to lead to further efforts to address health care costs.
- view as grid
- view as list
Larry Levitt writes about the political and practical impact of the health care provisions in the Inflation Reduction Act in The New York Times guest essay, “The Biggest Health Care Reform in a Decade Could Lower Your Costs.”
The Uncertain Future of Policies to Promote Access and Affordability Put in Place During the COVID-19 Pandemic
In this column for the JAMA Health Forum, Larry Levitt highlights four changes implemented during the COVID-19 pandemic that helped to make health care more accessible and affordable and the prospects for those changes to telehealth, COVID-19 coverage, Medicaid and marketplace premiums continuing beyond the pandemic’s end.
KHN’s Céline Gounder and KFF’s Mollyann Brodie look at the challenges in returning to normal life after the COVID-19 pandemic when many Americans, particularly people of color and workers with low incomes, do not have paid sick leave.
This Health Affairs Grantwatch article summarizes findings from several KFF-Peterson Health System Tracker analyses with an emphasis on the COVID-19 pandemic’s impact through 2021 and a look ahead toward 2022.
In this column for the JAMA Health Forum, Larry Levitt examines how the No Surprises Act that prohibits unexpected out-of-network charges for patients could lead to lower payment rates and revenues for some doctors and other care providers.
In this commentary for Barron’s, Cynthia Cox and Lindsey Dawson examine the cost and availability of at-home COVID-19 tests and how the new Biden administration policy requiring private insurances to cover their costs may work.
In this Axios column, Drew Altman examines the data about what parents say they will do once their children ages 5-11 become eligible for a COVID-19 vaccine, and why it will take some time and a concerted outreach effort to match adult vaccination rates.
In this column for the JAMA Health Forum, Larry Levitt explores why the Medicaid “coverage gap” still exists in 12 states that have not expanded their Medicaid programs under the Affordable Care Act, why it matters, and why eliminating it could prove challenging.
In this Axios column, Drew Altman takes on the idea that communities of color are behind the problem of the unvaccinated in the U.S.